Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

GILD slides 2.6% after FDA halts trials for HIV candidates, GS-1720 and GS-4182, over safety concerns in patients.

The first trilogue negotiations between EU lawmakers over the long-awaited reform to Europe’s pharmaceutical legislation will ...

BeOne Medicines (NASDAQ:ONC) gains FDA approval for a new tablet version of Brukinsa, simplifying dosage for patients.

A European health authority has found that medications containing semaglutide—such as Ozempic, Wegovy, and Rybelsus—can ...

The University of Oxford has received support from European Medicines Agency's (EMA) for its vaccine targeting the deadly ...

DEP, the most common plasticiser in softgels, is considered to have relatively low toxicity and is used in small amounts. The ...

DEP, the most common plasticiser in softgels, is considered to have relatively low toxicity and is used in small amounts. The ...

Advert Previous studies linked the drug to a rare eye condition known as non-arteritic anterior ischemic optic neuropathy ...

ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced updated data from the LOTIS-7 Phase 1b open-label clinical trial ...

EU pushes for India to ease Quality Control Orders in FTA negotiations, but concerns arise over foreign interference.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of ...